The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Mechanisms linking obesity with cardiovascular disease
Abstract
Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity is strongly associated with the development of major risk factors for atherosclerotic disease such as hypertension, hyperlipidemia, and diabetes (79, 89, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In addition, endothelial dysfunction is widely present in obesity and the metabolic syndrome (84, 325, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In other populations, such as those in the STRONG heart study (native Americans of the western United States) and the Framingham heart study, diabetes or the metabolic syndrome do appear to be significant risk factors for LV hypertrophy (272, 306, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,009
Momeni, A., Ahdoot, M. A., Kim, R. Y., Leroux, E., Galaiya, D. J., & Lee, G. (2011) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2011.10.005 · Cited by 43
Resistance to Diet-Induced Obesity in Mice with Synthetic Glyoxylate Shunt
Dean, J. T., Tran, L. M., Beaven, S. W., Tontonoz, P., Reue, K., Dipple, K. M., & Liao, J. C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.04.008 · Cited by 41
Iyer, A., & Brown, L. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep090 · Cited by 42
DNA damage response signaling: A common link between cancer and cardiovascular diseases
Nikfarjam, S., & Singh, K. K. (2022) · Cancer Medicine · doi:10.1002/cam4.5274 · Cited by 45
Roy, P. K., Islam, J., & Lalhlenmawia, H. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00352-7 · Cited by 51
Purine Bases Oxidation and Repair Following Permethrin Insecticide Treatment in Rat Heart Cells
Vadhana, M. S. D., Nasuti, C., & Gabbianelli, R. (2010) · Cardiovascular Toxicology · doi:10.1007/s12012-010-9079-6 · Cited by 41
Dozio, E., Malavazos, A. E., Vianello, E., Briganti, S., Dogliotti, G., Bandera, F., Giacomazzi, F., Castelvecchio, S., Menicanti, L., Sigrüener, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090960 · Cited by 41
Conner, J. D., Wolden‐Hanson, T., & Quinn, L. S. (2014) · Journal of Visualized Experiments · doi:10.3791/51846 · Cited by 43
Vinet, A., Obert, P., Dutheil, F., Diagne, L., Chapier, R., Lesourd, B., Courteix, D., & Walther, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2704 · Cited by 41
“The induction of alow-gradeinflammatorystateandthederivedendothelialdysfunction are currently considered to be the two major mechanisms responsible for this increased cardiovascular risk (1).”
BackgroundHou, X., Liu, Y., Lu, H., Ma, X., Hu, C., Bao, Y., & Jia, W. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1064 · Cited by 41
“As obesity is an important and fundamental risk factor for cardiometabolic disorders, cardiovascular diseases and premature mortality [4-6], depicting the changing trends in obesity helps comprehend the prevalence of obesity-related chronic diseases and allows us to alert and inform the care professionals and the publ…”
BackgroundThe mechanism by which moderate alcohol consumption influences coronary heart disease
Mathews, M. J., Liebenberg, L., & Mathews, E. H. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0011-6 · Cited by 43
“97 [30] 98 [27,72,121,131] 99 [30] 100 [121] 101 [115-117] 102 [30,76,79,115,121,129]”
InfluentialThe metabolic vascular syndrome - guide to an individualized treatment
Hanefeld, M., Pistrosch, F., Bornstein, S. R., & Birkenfeld, A. L. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9345-4 · Cited by 44
“Inflammatory cytokines are involved in the induction of endothelial dysfunction and insulin resistance [30].”
BackgroundGu, Y., Hu, K., Huang, Y., Zhang, Q., Liu, L., Ge, M., Wu, H., Xia, Y., Bao, X., Shi, H., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.041 · Cited by 43
Dietary Composition and Cardiovascular Risk: A Mediator or a Bystander?
Korakas, E., Dimitriadis, G., Raptis, A. E., & Lambadiari, V. (2018) · Nutrients · doi:10.3390/nu10121912 · Cited by 48
“In addition, accumulation of lipids within muscle cells and hepatocytes leads to further insulin resistance and abnormal glucose uptake [7].”
BackgroundTsai, C., Pan, C., Chen, F., Huang, T., Tsai, M., & Chuang, C. (2019) · Experimental Physiology · doi:10.1113/ep087862 · Cited by 41
Piek, A., Koonen, D. P. Y., Schouten, E., Lindtstedt, E. L., Michaëlsson, E., de Boer, R. A., & Silljé, H. H. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-55263-y · Cited by 41
Lan, J., Tong, R., Xiao-Meng, S., Hao-Yue, Z., Sun, S., Xiong, A., Wang, Z., & Yang, L. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153362 · Cited by 41
Krishnasamy, R., Hawley, C. M., Stanton, T., Pascoe, E. M., Campbell, K. L., Rossi, M., Petchey, W. G., Tan, K., Beetham, K. S., Coombes, J. S., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0098-1 · Cited by 41
“Obesity is related to activation of inflammatory cytokines, especially tumour necrosis factor (TNF), that contribute to fibrotic changes of the myocardium [43].”
BackgroundWilli, S., Hirst, K., Jago, R., Buse, J., Kaufman, F., Ghormli, L. E., Bassin, S., Elliot, D., & Hale, D. (2012) · Pediatric obesity · doi:10.1111/j.2047-6310.2011.00042.x · Cited by 44
“It is known that crossing BMI thresholds towards obesity is associated with increases in cytokines and bioactive mediators that adversely affect cardiovascular health (27).”
BackgroundCartier, A., Côté, M., Bergeron, J., Alméras, N., Tremblay, A., Lemieux, I., & Després, J. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03671.x · Cited by 41
Liu, J., Liu, W., Wang, L., Wang, N., Wu, L., Liu, X., Liu, Z., Zhou, Y., Yin, X., Liu, Y., et al. (2024) · Nutrients · doi:10.3390/nu16142277 · Cited by 46
“First, an excessive accumulation of visceral fat may release proinflammatory cytokines and increase systemic inflammation risk, which are typical pathways for developing diabetes or cardiovascular diseases [26,27].”
BackgroundMetabolic Obesity, Adipocytokines, and Inflammatory Markers in Asian Indians—CURES-124
Indulekha, K., Surendar, J., Anjana, R., Geetha, L., Gokulakrishnan, K., Pradeepa, R., & Mohan, V. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0202 · Cited by 46
“There is convincing evidence that metabolic disorders like Type 2 diabetes (T2DM) and Metabolic syndrome (MS) and are associated with obesity [1].”
Myre, M., & Imbeault, P. (2013) · Obesity Reviews · doi:10.1111/obr.12086 · Cited by 41
“Obesity has become a leading worldwide health burden by increasing the risk of developing related health disorders such as type 2 diabetes (1), cardiovascular disease (2), and some types of cancer (3), among others.”
BackgroundThe association between cheese consumption and cardiovascular risk factors among adults
Houston, D. K., Driver, K. E., Bush, A. J., & Kritchevsky, S. B. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00853.x · Cited by 40
Very Low Carbohydrate Diet Significantly Alters the Serum Metabolic Profiles in Obese Subjects
Gu, Y., Zhao, A., Huang, F., Zhang, Y., Liu, J., Wang, C., Jia, W. P., Xie, G., & Jia, W. (2013) · Journal of Proteome Research · doi:10.1021/pr4008199 · Cited by 44
Stefanov, T., Vekova, A., Bonova, I., Tzvetkov, S., Kurktschiev, D. P., Blüher, M., & Temelkova-Kurktschiev, T. S. (2013) · Central European Journal of Public Health · doi:10.21101/cejph.a3801 · Cited by 39
Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes
Obeid, A., Long, J., Kakade, M. S., Clements, R. H., Stahl, R. D., & Grams, J. M. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2375-4 · Cited by 41
“Obesity is associated with an increased risk of metabolic syndrome, type 2 diabetes mellitus, cardiovascular disease, and cancer [3–7].”
BackgroundEffect of the diet components on adiponectin levels.
Reis, C. E. G., Bressan, J., & Alfenas, R. D. C. G. (2010) · PubMed · Cited by 40
Crump, C., Sundquist, J., Winkleby, M. A., & Sundquist, K. (2016) · International Journal of Stroke · doi:10.1177/1747493016641961 · Cited by 40
“Both increased adiposity and reduced physical fitness are known to have adverse effects on insulin sensitivity, lipid metabolism, autonomic tone, fibrinolysis, and inflammation, which contribute to endothelial dysfunction and atherosclerosis.(38,39) Obesity and physical inactivity are associated with higher levels of…”
‘Adiposopathy’ and cardiovascular disease
Appachi, S., & Kashyap, S. R. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283642a33 · Cited by 42
“After bariatric surgery, tin, and CRP cause amelioration of all of these risk factors om [1].”
BackgroundKunutsor, S. K., Bakker, S. J. L., Blokzijl, H., & Dullaart, R. P. F. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.01.008 · Cited by 40
Metabolically healthy obesity and the risk for subclinical atherosclerosis
Kim, T. J., Shin, H., Chang, Y., Kang, M., Jee, J., Choi, Y., Ahn, H. S., Ahn, S. H., Son, H. J., & Ryu, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.035 · Cited by 40
Sullivan, E. M., Fix, A., Crouch, M. J., Sparagna, G. C., Zeczycki, T. N., Brown, D. A., & Shaikh, S. R. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.004 · Cited by 41
“Obesity contributes to cardiovascular complications by increasing dyslipidemia, hypertension, and glucose dysregulation [30].”
Aerobic fitness, muscular strength and obesity in relation to risk of heart failure
Crump, C., Sundquist, J., Winkleby, M. A., & Sundquist, K. (2017) · Heart · doi:10.1136/heartjnl-2016-310716 · Cited by 40
Obesity and Altered Aspirin Pharmacology
Norgard, N. B. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0611-8 · Cited by 41
Ritter, A., Kreis, N., Roth, S., Friemel, A., Jennewein, L., Eichbaum, C., Solbach, C., Louwen, F., & Yuan, J. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1373-z · Cited by 40
Gowda, S. G. B., Zi-Jun, G. A. O., Chen, Z., Abe, T., Hori, S., Fukiya, S., Ishizuka, S., Yokota, A., Chiba, H., & Hui, S. (2020) · Analytical Sciences · doi:10.2116/analsci.19p442 · Cited by 40
Serotonin Regulates De Novo Lipogenesis in Adipose Tissues through Serotonin Receptor 2A
Shong, K. E., Oh, C., Namkung, J., Park, S., & Kim, H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.470 · Cited by 41
Multimorbidity and obesity in older adults from six low- and middle-income countries
Romano, E., Ma, R., Vancampfort, D., Firth, J., Félez-Nóbrega, M., Haro, J. M., Stubbs, B., & Koyanagi, A. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106816 · Cited by 38
Weight loss reduces dyspnea on exertion in obese women
Bernhardt, V., & Babb, T. G. (2014) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2014.09.004 · Cited by 41
HIV is an independent predictor of aortic stiffness
Rider, O. J., Asaad, M., Ntusi, N., Wainwright, E., Clutton, G., Hancock, G., Banerjee, R., Pitcher, A., Samaras, K., Clarke, K., et al. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-014-0057-1 · Cited by 40
“Moreover, hsCRP was not only elevated in patients with HIV in this study but was also positively correlated to aortic PWV and negatively correlated to AD at all three levels, and furthermore was strongly correlated with visceral fat, which is thought to play a central role in this inflammatory process, with macrophage…”
ResultVerhagen, S. N., Rutten, A., Meijs, M. F. L., Išgum, I., Cramer, M. J., van der Graaf, Y., & Visseren, F. L. J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.091 · Cited by 40
“Abdominal obesity is a risk factor for the development of cardiovascular diseases by inducing systemic metabolic disturbances, such as inflammation, insulin resistance, dyslipidemia, and hypercoagulability [14].”
BackgroundQuality-of-Life Assessment after Medial Thighplasty in Patients following Massive Weight Loss
Bertheuil, N., Thiénot, S., Chaput, B., Varin, A., & Watier, É. (2015) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000000771 · Cited by 40
Resveratrol improves muscle regeneration in obese mice through enhancing mitochondrial biogenesis
Niu, W., Wang, H., Wang, B., Mao, X., & Du, M. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108804 · Cited by 39
Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis
Shirazi, F., Farmakiotis, D., Yan, Y., Albert, N. D., Do, K.-A., & Kontoyiannis, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108635 · Cited by 39
“In DM2, persistently elevated glucose levels have been shown to suppress both adaptive and innate immunity [1].”
BackgroundResultInfluentialAdipose tissue distribution in children: Automated quantification using water and fat MRI
Kullberg, J., Karlsson, A., Stokland, E., Svensson, P., & Dahlgren, J. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22193 · Cited by 39
Forkhead Box O-1 Modulation Improves Endothelial Insulin Resistance in Human Obesity
Karki, S., Farb, M. G., Ngo, D. T. M., Myers, S. J., Puri, V., Hamburg, N. M., Carmine, B. J., Hess, D. T., & Gokce, N. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.305139 · Cited by 39
Borges, M. C., Oliveira, I. O., Freitas, D. F., Horta, B. L., Ong, K. K., Gigante, D. P., & Barros, A. J. D. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx022 · Cited by 39
“40 Overproduction of adiponectin in animal models can induce substantial expansion of subcutaneous fat depots, 41 which is consistent with the capacity of adiponectin to activate peroxisome proliferator activator receptor (PPAR)- c , a key transcription factor of adipogenesis.”
BackgroundSantos, L. R. B., & Fleming, I. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106407 · Cited by 44
He, X., Guo, B. J., Lei, Y., Wang, T., Fu, Y., Curran, W. J., Zhang, L. J., Liu, T., & Yang, X. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab8077 · Cited by 40
“Plausible mechanisms that could account for the EAT-related abnormalities include changes in blood pressure, blood glucose regulation, lipid metabolism and overall systemic inflammation (Van Gaal et al 2006).”
BackgroundImplications of metabolism-driven myeloid dysfunctions in cancer therapy
Strauss, L., Guarneri, V., Gennari, A., & Sica, A. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00556-w · Cited by 39
“Metabolic comorbidities may adversely affect patient survival and quality of life and might be an important link between cancer treatment cardiovascular toxicity and accelerated atherosclerosis in cancer survivors.(173) Obesity is a contributing factor to the higher occurrence of metabolic syndrome and cardiovascular…”
BackgroundCzumaj, A., Śledziński, T., & Mika, A. (2022) · Nutrients · doi:10.3390/nu14112310 · Cited by 41
Tuncay, E., & Turan, B. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0423-3 · Cited by 39
Schaun, M. I., Dipp, T., Rossato, J. D. S., Wilhelm, E. N., Pinto, R. S., Rech, A., Plentz, R. D. M., de Bittencourt, P. I. H., & Reischak-Oliveira, Á. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1781 · Cited by 39
Diagnostic Utility of 18F-FDG PET/CT in Inflammation of Unknown Origin
Balink, H., Bennink, R. J., Veeger, N. J. G. M., van Eck‐Smit, B. L. F., & Verberne, H. J. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000423 · Cited by 39
“Adipose tissue is an active endocrine organ that releases a variety of hormones and cytokines, such as interleukin 6, that contribute to CRP elevation.(31) (18)F-FDG PET/CT may guide further diagnostic procedures, for example, by more precisely targeted CT-guided biopsies, which minimizes the risk of a sample error.”
BackgroundMiller, E. G., Sethi, P., Nowson, C. A., Dunstan, D. W., & Daly, R. M. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3657-2 · Cited by 39
“As such, obesity has been associated with subclinical systemic inflammation, which may explain in part its link to insulin resistance and the development of type 2 diabetes (Lee et al. 2014; Van Gaal et al. 2006).”
BackgroundZimmermann, E., Skogstrand, K., Hougaard, D. M., Astrup, A. V., Hansen, T. F., Pedersen, O. B., Sørensen, T. I. A., & Jess, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015958 · Cited by 38
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
Derdemezis, C. S., Kiortsis, D. N., Tsimihodimos, V., Petraki, M. P., Vezyraki, P., Elisaf, M., & Tselepis, A. D. (2011) · Biochemistry Research International · doi:10.1155/2011/285618 · Cited by 38
Exosomal microRNA-194 causes cardiac injury and mitochondrial dysfunction in obese mice
Nie, H., Pan, Y., & Zhou, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.113 · Cited by 39
Li, F., Zhang, K., Xu, T., Du, W., Yu, B., Liu, Y., & Nie, H. (2018) · Endocrine · doi:10.1007/s12020-018-1753-7 · Cited by 37
Gou, L., Liu, G., Ma, R., Regmi, A., Zeng, T., Zheng, J., Zhong, X., & Chen, L. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00459-7 · Cited by 38
Teklehaimanot, W. H., Duodu, K. G., & Emmambux, M. N. (2013) · Starch - Stärke · doi:10.1002/star.201200244 · Cited by 38
“Production of low-calorie foods has been developed due to the positive relation between lifestyle diseases such as diabetes and cardiovascular diseases and consumption of high fat food [1–3].”
BackgroundHDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight
Pietiläinen, K. H., Söderlund, S., Rissanen, A., Nakanishi, S., Jauhiainen, M., Taskinen, M., & Kaprio, J. A. (2009) · Obesity · doi:10.1038/oby.2008.675 · Cited by 38
Jiang, W., Zhu, Z., & Thompson, H. J. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0169 · Cited by 38
Torre-Villalvazo, I., Gonzalez, F., Aguilar-Salinas, C. A., Tovar, A. R., & Torres, N. (2009) · Journal of Nutrition · doi:10.3945/jn.109.109769 · Cited by 38
Dias, K. A., Coombes, J. S., GREEN, D. J., Gomersall, S. R., Keating, S. E., Tjønna, A. E., Hollekim-Strand, S. M., Hosseini, M. S., Rø, T. B., Haram, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010929 · Cited by 38
“stantial impact on insulin sensitivity, inflammation and subsequent risk for dyslipidaemia, T2DM and atherosclerosis.(24) Current paediatric guidelines for treating paediatric obesity recommend lifestyle modification to encourage family-based behaviour change leading to a reduction in energy intake and increase in phy…”
Song, J., Jang, Y., Lim, S.-Y., Ryu, S., Song, W. J., Byrne, C. D., & Sung, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208736 · Cited by 38
The impacts of visual street environments on obesity: The mediating role of walking behaviors
Kim, J.-I., Yu, C.-Y., & Woo, A. (2023) · Journal of Transport Geography · doi:10.1016/j.jtrangeo.2023.103593 · Cited by 37
Association between stroke and relative fat mass: a cross-sectional study based on NHANES
Zheng, Y., Huang, C., Jin, J., Zhao, Y., Cui, H., & Wei, C. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02351-2 · Cited by 37
“These dyslipidemic conditions represent crucial risk factors for atherosclerosis [46].”
BackgroundRelationship between non‐alcoholic fatty liver disease and pulmonary function
Jung, D., Shim, J., Lee, H. ‐., Moon, B.-S., Park, B., & Lee, Y. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02644.x · Cited by 37
Lee, H., Jee, Y., Hong, K., Hwang, G. S., & Chun, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083471 · Cited by 38
“hypertension, and coronary heart disease [1-3][1-3].”
Association of Plasma Pentraxin 3 With Arterial Stiffness in Overweight and Obese Individuals
Miyaki, A., Maeda, S., Choi, Y., Akazawa, N., Eto, M., Tanaka, K., & Ajisaka, R. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt103 · Cited by 37
Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation
Han, R., Wang, X., Bachovchin, W. W., Żukowska, Z., & Osborn, J. W. (2015) · Scientific Reports · doi:10.1038/srep12348 · Cited by 35
Seven, E., Thuesen, B. H., Linneberg, A. R., & Jeppesen, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07306 · Cited by 37
Chitra, S., Rajakannu, A., Arunadevi, R., Gaidhani, S. N., Ilavarasan, R., & Singh, D. V. K. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2016.12.002 · Cited by 37
“, elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDLc) [1], and other important contributors to this disease include inflammation, oxidative stress and insulin resistance [2,3].”
BackgroundFerrandi, P. J., Fico, B. G., WHITEHURST, M. A., Zourdos, M. C., Bao, F., Dodge, K. M., Rodriguez, A. L., Pena, G. S., & Huang, C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.007 · Cited by 39
Oh, S.-K., Cho, A., Kwon, Y., Lee, H. S., & Lee, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203787 · Cited by 37
Dietary antioxidant for disease prevention corroborated by the Nrf2 pathway
Hegazy, A. M., El-Sayed, E. M., Ibrahim, K. S., & Abdel-Azeem, A. S. (2019) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2018-0161 · Cited by 38
Banba, A., Tsuji, A., Kimura, H., Murai, M., & Miyoshi, H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007687 · Cited by 40
Zhang, P., Liu, Y., Ren, Y., Bai, J., Zhang, G., & Cui, Y. (2019) · African Health Sciences · doi:10.4314/ahs.v19i3.35 · Cited by 40
Goodarzi, G., Setayesh, L., Fadaei, R., Khamseh, M. E., Aliakbari, F., Hosseini, J., & Moradi, N. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06551-2 · Cited by 37
Fan, N., Zhao, J., Zhao, W., Shen, Y., Song, Q., Shum, H. C., Wang, Y., & Rong, J. (2021) · Biomaterials Science · doi:10.1039/d1bm01637g · Cited by 37
Mei, Y., Williams, J. S., Webb, E. K., Shea, A. K., MacDonald, M. J., & Al‐Khazraji, B. K. (2022) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2022.825147 · Cited by 37
Alorfi, N. M., & Algarni, A. S. (2022) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s374741 · Cited by 42
Significance of Adipose Tissue Maintenance in Patients Undergoing Hemodialysis
Okuno, S. (2021) · Nutrients · doi:10.3390/nu13061895 · Cited by 36
“Obesity, primarily defined by excess body fat mass, is highly prevalent and increasing worldwide and has been found to be associated with serious outcomes, including diabetes, hypertension, CVD, and mortality [6,7].”
BackgroundKhalafi, M., Sakhaei, M. H., Kazeminasab, F., Rosenkranz, S. K., & Symonds, M. E. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.05.024 · Cited by 45
Xiao, N., Ding, Y., Cui, B., Li, R., Qu, X.-R., Zhou, H., Au, K.-H., Fan, X.-D., Xie, J.-C., Huang, Y., et al. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100090 · Cited by 39
Taguchi, K., Matsumoto, T., Kamata, K., & Kobayashi, T. (2012) · Endocrinology · doi:10.1210/en.2012-1101 · Cited by 36
“of cardiovascular morbidity and mortality (3, 4).”
Bertheuil, N., Thiénot, S., Huguier, V., Menard, C., & Watier, É. (2013) · Aesthetic Plastic Surgery · doi:10.1007/s00266-013-0245-7 · Cited by 35
“Obesity is a major health risk factor because of associated medical complications such as cardiovascular disease, hyperlipidemia, diabetes, high blood pressure, cancer, degenerative arthritis and sleep apnea [1-4].”
BackgroundDong, B., Wang, Z., Wang, H.-J., & Ma, J. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.95 · Cited by 36
Herová, M., Schmid, M., Gemperle, C., Loretz, C., & Hersberger, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.912 · Cited by 37
Keijer, J., & van Schothorst, E. M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f39f95 · Cited by 36
Zeng, R., Xu, C., Xu, Y., Wang, Y., & Wang, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003390 · Cited by 36
“Among these risk markers, obesity has been shown to be highly associated with CVD (3), and the underlying mechanism has been fully depicted (4).”
BackgroundVerhulst, S. L., Rooman, R., Gaal, L. V., Backer, W. D., & Desager, K. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.152 · Cited by 36
Gray, C. L., Harrison, C. J., Segovia, S. A., Reynolds, C. M., & Vickers, M. H. (2015) · Scientific Reports · doi:10.1038/srep09753 · Cited by 37
Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets
Vasconcelos, L. H. C., de Souza, I. L. L., Pinheiro, L. S., & da Silva, B. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00058 · Cited by 36
“…to weight gain and the development of chronic disorders, including arterial hypertension, type 2 diabetes mellitus, dyslipidemias, sleep apnea, and cancer (Jeffreys et al., 2003; Van Gaal et al., 2006; Pischon et al., 2008; Whitlock et al., 2009; Vucenik and Stains, 2012; Singh et al., 2013).”
BackgroundVascular risk in obesity: Facts, misconceptions and the unknown
King, R., & Ajjan, R. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116675488 · Cited by 39
Bonato, M., Galli, L., Passeri, L., Longo, V., Pavei, G., Bossolasco, S., Bertocchi, C., Cernuschi, M., Balconi, G., Merati, G., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2095-9 · Cited by 36
“First, the reduction of fat mass following physical activity may promote an anti-inflammatory environment via reduced infiltration of immune cells in the adipose tissue and release of adipokines, including pro-inflammatory cytokines [39].”
BackgroundTamucci, K. A., Namwanje, M., Fan, L., & Qiang, L. (2017) · Protein & Cell · doi:10.1007/s13238-017-0434-2 · Cited by 39
“Obesity confers an increased risk of developing insulin resistance, type 2 diabetes mellitus, and cardiovascular disease (Van Gaal et al. 2006; Guilherme et al. 2008).”
BackgroundMitani, T., Watanabe, S., Yoshioka, Y., Katayama, S., Nakamura, S., & Ashida, H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.09.017 · Cited by 36
“Introduction 1 Obesity is a serious health problem in both developed and developing countries and 2 increases the incidence of many diseases, such as cardiovascular disease, hypertension 3 and type 2 diabetes mellitus [1, 2].”
Background
Metadata
- Authors
- Van Gaal, L. F., Mertens, I. L., & De Block, C. E.
- Affiliations
- University of Antwerp (BE)
- Venue
- Nature
- Published
- 2006-12
- Volume
- 444
- Issue
- 7121
- Pages
- 875-880
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964607854
- Cited by
- 2,814
- References
- 86
- Citations by year
- 2026: 64 · 2025: 97 · 2024: 126 · 2023: 137 · 2022: 151 · 2021: 172 · 2020: 179 · 2019: 204 · 2018: 172 · 2017: 173 · 2016: 168 · 2015: 193 · 2014: 194 · 2013: 152 · 2012: 128
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, adipose tissue, adipokines, insulin resistance, type 2 diabetes, dyslipidemia, blood pressure, coagulation, fibrinolysis, inflammation, endothelial dysfunction, atherosclerosis, smoking, physical activity, premature mortality
- MeSH terms
- Cardiovascular Diseases, Endothelium, Vascular, Humans, Insulin Resistance, Obesity, Oxidative Stress, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review